SEI Investments’s Journey Medical DERM Stock Holding History

SEI Investments’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-109,351	Closed	-$843K	–	3264
2025 Q4	$843K	Buy	+109,351	New	+$857K	﹤0.01%	2253

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SEI Investments's DERM Position: Q1 2026 in Review

SEI Investments sold out of Journey Medical (DERM) in Q1 2026, closing a stake of 109,351 shares — an estimated $843K sold.

SEI Investments first reported a position in DERM in Q4 2025 and held it in 1 quarter. The position peaked at $843K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

SEI Investments reported no remaining Journey Medical position as of Q1 2026 after selling out during the quarter.
SEI Investments sold 109,351 Journey Medical shares in Q1 2026, an estimated $843K.
SEI Investments first reported a position in Journey Medical in Q4 2025 and held it in 1 quarter.
SEI Investments's Journey Medical position peaked at $843K in Q4 2025.
71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.